MicroVas Investor's Forum

2011-04-06T09:47:00.001-07:00

EXCLUSIVE MAKER- MARKETER of the MicoVas EchoPulse Innovation. 6130 South Memorial Drive, Tulsa, OK 74133 Phone: 918-250-9996 or Toll Free: 1-86-MICROVAS Fax: 918-252-4888 email: info@microvas.com

Sports Medicine

2011-04-01T13:38:00.000-07:00

The MicroVas System provides a solid foundation for rebuilding athletic performance through a unique, proprietary technology that takes Physical Medicine and electrical stimulation to the next level

Basic Benefits:

Increased Circulation
MicroVas treatments immediately and dramatically increases blood flow(1) which perfuses the capillary beds and elevates tissue oxygenation, aids in fibroblast proliferation and collagen formation(2), upregulates platelet derived growth factors and boosts transcapillary exchange of nutrients.

Involuntary Exercise
Retrains and rebuilds muscle, aids in restoring flexion, range of motion and strength. Elevates metabolism and production of local metabolites.

Lymphatic Drainage
Boosts lymphatic drainage from 10-fold to
30-fold(3), which relieves swelling and inflammation, decompresses nerves in constricted spaces and boosts the body's immune responses.

Pain Management
Palliative effects of MicroVas include the blocking of neurological transmission of pain signals and stimulation of endorphins.

I was suffering from acute tendinitis in my arm which severely impacted my pitching. Seeking relief, I went to see Dr. James R. Andrews at the HealthSouth Sports Medicine and Rehabilitation Center in Birmingham, Alabama where he prescribed a new technology for me: the MicroVas vascular treatment system. The treatments I received helped me get back on the mound for the playoffs.

John Smoltz, Pitcher - The Atlanta Braves

Real Healing Doesn't Occur Until Torn Muscle Fibers, Ligaments or Tendons Are Repaired

Most of what we do following an injury

is designed to make the athlete feel

better: to reduce pain and swelling. We sometimes forget that the inflammatory re-
sponse is part of the body's defense

against injury.

___The heat and redness that accom-

pany injury, indicate tissue perfusion

and are a sign that the body is deliver-

ing more blood, oxygen and nutrients

to the injured area. Capillaries become
"leaky" which leads to an increase in
interstitial fluid, which , in turn, elevates

the volume of lymphatic drainage and triggers the body's immune responses.
The "leaky" capillaries also give rise to an elevated level of platelet derived
growth factors which are crucial to new tissue growth. The pain, of course,
is to encourage the athlete to give it a rest.

___R.I.C.E., or Rest, Ice, Compression and Elevation, is the Gold Stan-

dard of sports injury care because it works. But RICE+MicroVas works even

better! Here's why:

After injury, the inflammatory response causes capillaries to dilate. The

capillary walls increase in permeability allowing more plasma to leak into the intercellular spaces. The liquid accumulates between cells causing swelling.
Applying ice to the injury constricts the capillaries to minimize leakage into

the extracellular space and also serves to numb the pain. This application of

ice, however, also constricts the lymphatic vessels and thus slows drainage

and by constricting blood flow, diminishes the supply of oxygen and nutri-

ents needed for the proliferation and remodeling stages of healing.

.... MicroVas stimulates the lymphatic system(3) to upregulate drainage, de-

crease swelling and boost the body's immune responses. At the same time, it promotes blood flow to help deliver more oxygen and nutrients to aid in the proliferation and remodeling stages.

___So RICE for one or two days, then apply MicroVas for a faster recovery. MicroVas
therapy also provides "no-load" exercise which has been found equal to vo-
litional strength training(4) for the muscles to help keep them in tone during
recovery while waiting for the injury to heal enough for traditional physical
therapy and exercise.

1. Clinical Study: University of Oklahoma Health Science Center, unpublished, 1999
2. Lawrence B. Harkless, D.P.M., et al, Seven Keys to Treating
Chronic Wounds Podiatry Today
3. Guyton's Textbook of Medical Physiology, 8th Edition, pp 182-
183

MicroVas K023230 (EchoPulse)

2011-04-01T12:39:00.000-07:00

MicroVas K891987

2011-04-01T12:37:00.000-07:00

Microvas K972055

2011-04-01T12:35:00.000-07:00

Microvas Patent # 7844339 (excepts, without engineering notes)

2011-04-01T11:14:00.000-07:00

PROCEDURE AND MACHINE FOR ELECTRO-INDUCING/STIMULATING DEEP-LAYERED MUSCLE CONTRACTIONS USING A BIPHASIC FARADIC PULSE SEQUENCE

Abstract

Abstract of CA2483412 A procedure and machine promotes healing by causing muscle fasciculation and contraction relaxation cycles that effectively pump blood through the microcirculation, draining the venous beds and raising the tissue oxygen levels. A high phase charged system, a power source, timer and pulse generator is electronically pulsed and adjusting to induce deep-layered muscle contractions, causing greatly increased flow rates of both blood and lymphatics, patency of vessels permitting, and forcing blood into the microcirculation of the treated tissue. The machine electrical waveform stimulates angiogenesis, facilating new tissue growth and repair in the healing process and raises the metabolic rate in the treated tissues.

Claims

WHAT IS CLAIMED IS:

1. A procedure for therapeutic treatment of human and animal tisues comprising the steps of: identifying the tissue to be treated; sandwiching the identified tissue between one or more pairs of opposed emitter pads in contact with the skin; and applying a biphasic faradic pulse sequence to the pairs of emitter pads to stimulate deep layered muscle contractions in the identified tissues.

Description

.
PROCEDURE AND MACHINE FOR ELECTRO-INDUCING / STIMULATING DEEP-LAYERED MUSCLE CONTRACTIONS USING A BIPHASIC FARADIC PULSE SEQUENCE BACKGROUND OF THE INVENTION:
.
This invention generally relates to therapeutic treatment of human and animal tissues and more particularly concerns a procedure and machine for electro-inducing or stimulating deep layered muscle contractions in tissues for the purpose of healing and treating wounds and various vascular deficiency ailments such as peripheral vascular disease, ischemic rest pain, diabetic neuropathy, pressure ulcers, slow or non-healing wounds, chronic low back pain, osteoarthritis, occupational problems such as carpal-tunnel syndrome, tendonitis and other sports injuries.
.
An underlying characteristic of the above conditions and diseases is impaired circulation in-the capillary beds as well as nerve damage. Without blood flow to the tissues, oxygen and nutrients cannot get into the tissues and the waste products of metabolism cannot get out. This puts a severe stress on the tissues causing them to go into a survival mode. The cells use what limited resources they have to stay alive and higher functions, including healing and repair,as well as tissue mediated immunity, become essentially shut down. In most patients with severe disease, measured tissue oxygen levels have been found to be less than 15% of normal. Diabetics with impaired basement membrane function, Reynauds phenomena, Claudication states and other similar conditions all may have similar features due to this underlying characteristic.
.
Essentially, every tissue in the body has intrinsic electrical properties.
.
Because of this, it has been found that they respond to electrical stimulation.
.
There have been many machines designed over the years to use electricity to affect the body in various ways to enhance the healing process. There are many variables in the use of electricity, including polarity, voltage, amperage, frequency and waveform. Although there are a variety of alternate technologies available today, the electronic parameters of known machines have limited applications.

Hyperbaric oxygen therapy has been shown to be effective in healing ischemic ulcers. 100% oxygen at 2 atmospheres will give a partial pressure of oxygen 10 times normal. This greatly increases the rate of diffusion through the open face of the ulcer. Skin, however, is not as permeable to oxygen diffusion and oxygen delivery depends upon intact circulation as well. Hyperbaric oxygen therapy is a passive process and does not alter the underlying disease in the microcirculation.
.
There are several procedures in practice using moist heat with occlusion dressings, infrared lamps, membranes with electrical currents and warm water whirlpool treatments. These have all shown some merit and have been effective in varying degrees. They all work by stimulating the arterioles in the capillary beds to dilate in response to infrared energy. These also are passive procedures, however, and do not alter the underlying disease in the microcirculation.
..
Machines using high frequency interferential electrical currents are also effective. They stimulate the nerves in the skin and cause dilation of the capillary beds through the reflex pathways. However, this form of electrical current tends to be more superficial in the tissues and, therefore, less decisive and rapid in its healing effects.
.
Another procedure being used today consists of a garment placed around the diseased limb. Intermittent compression is then administered via compressed air from the attached machine. This again has proven to be effective to promote circulation and healing. by pumping the blood through the capillary beds. Pressure gradients are increased in the capillary beds but there is not necessarily the dilation of the arterioles as the other methods promote.
.
This procedure does not remodel themicrocirculation either.
.
It is, therefore, an object of this invention to provide an electrical tissue treating procedure and machine which increases circulation in capillary beds.
.
Another object of this invention is to provide an electrical tissue treating procedure and machine which significantly remodels microcirculation so as to provide more permanent therapeutic improvement. A further object of this invention is to provide an electrical tissue treating procedure and machine which not only dilates arterioles but also, increases pressure gradients across the capillary beds to improve flow and oxygen levels and promote angiogenesis.
.
Yet another object of this invention is to provide an electrical tissue treating procedure and machine which provides deep layered muscle contractions and perfuses tissues with blood so as to afford more decisive and rapid healing than known methods and machines. It is also an object of this invention to provide an electrical tissue treating procedure and machine which facilitates more rapid and decisive healing of vascular deficiency ailments than known procedures and machines.
.
SUMMARY OF THE INVENTION :
.
In accordance with the invention, a procedure and machine are provided to promote healing by causing muscle fasciculation and contraction-relaxation cycles that effectively pump blood through the microcirculation, draining the venous beds and raising the tissue oxygen levels. This, in turn, supplies the oxygen and substrates necessary to greatly accelerate the healing process.
.
Pressure gradients are actually increased across the capillary beds with perfusion of blood into the designated area of the patient, in contrast to merely dilating the capillary beds. Therefore, the treatment has a potent effect on the microcirculation, which results in dramatic responses to treatment.
.
Transcutaneous oxygen monitors have demonstrated marked increases in tissue oxygen levels within minutes of initiating treatment. Tissue oxygen levels with successive treatments continue to improve.
.
A high phase charged system is electronically pulsed and adjusted to induce deep-layered muscle contractions, causing greatly increased flow rates of both blood andlymphatics, patency of vessels permitting, and forcing blood into the microcirculation of the treated tissue.

The machine electrical waveform stimulatesangiogenesis, that is, budding of new capillaries and generation of denser capillary networks in the tissues. This lays the groundwork for new tissue growth and repair in the healing process. The machine electrical waveform also raises the metabolic rate in the treated tissues, which, it is theorized, helps the intimal lining of the arteries to metabolize the excess unused nutrients clogging them. Whatever the actual cause, the effect is improved blood flow that has been shown to be permanent, particularly in patients with neuropathy.
.
The procedure and machine have been tested on diabetics with severe ischemic ulcers in feet that were destined for amputation. This condition is usually associated with underlying osteomeyelitis, which does not respond well to standard therapy including systemic antibiotics and wound care. The present treatment greatly improves the management of this condition because the enhanced blood flow brings enhanced levels of antibiotics and healing to the affected area. In almost every case, the feet have been salvaged.
.
In addition, the machine's electrical waveform directly stimulates the activity of fibroblasts in the healing process. In the healing of ischemic ulcers the fibroblasts act first to build the framework upon which further cell types including skin and capillaries grow. The electrical current is a deep penetrating current that affects all tissues from the skin to the bone. Technically, the machine generates an [electrical] field between the emitter pads, in contrast to the electrical waveform of some machines that stay rather superficial in the tissues affecting primarily the top several millimeters. The system stimulates activity in bone cells as well, which accelerates fracture healing.
.
Finally, the procedure and machine have achieved excellent test case success in reversing neuropathy in the feet and legs of diabetics being treated.
.
In follow up on this condition thus far, improvement has persisted for extended periods of time. There is no other known technology or treatment modality that has reversed diabetic neuropathy. The reason for this unique therapeutic benefit is not known. It may be due to improvement in the circulation that nourishs the nerves or due to an unknown direct action on the nerves thernselves.
.
The procedure and machine have shown remarkable efficacy in dealing with the above difficult disease states. In comparison with the current alternative technologies on the market today, the present treatment has proven to cause more rapid and decisive healing. In addition, the patients have enjoyed permanent, persistent improvements in the circulation of the affected limb.
.
A treatment regimen of forty-five minutes a day has been effective in a very high percentage of patients treated resulting in remarkable changes in both neural conductivity and wound healing rates. Most importantly, patients report a high level of comfort with treatment.
.
Even with a relatively high phase charge, the comfort level to the patient remains acceptable over extended periods of time, during which the muscle groups are contracting. During moderate muscle contraction, blood rates can increase from 10 to 25 times the patient's resting blood flow. While only 20 to 25 percent of muscle capillaries are open during rest, nearly all of the dormant capillaries open up during moderate muscle contraction. Because of the decreased oxygen concentration in the tissue fluid (because of increased oxygen demands from the contracting muscles), vasodilation of the vessels is triggered by release of adenosine and other vasodilator substances, to the extent that any vasodilation is possible. In addition, lymph will not flow freely from resting muscle. However, the contracting muscles will squeeze or pump the lymph vessels and capillaries resulting in increased flow rates. With this increased fluid perfusion due to passive repetitive contractions (static work, an unopposed, involuntary muscle contraction) there is little tactic acid build up and most importantly there is more oxygenated blood, due to the pumping action of the muscles exerted on the arterial side.
.
As an example, take the lower leg as an area to be treated for healing a diabetic ulcer on the foot. The emitter pads are applied to the anterior and posterior muscle compartments of the lower leg. This will achieve muscle contractions in the anterior compartment, consisting of the anterior tibial and the extensor group and of the posterior compartment consisting of thegastrosoleus, flexors and peroneals. As these muscles pump oxygenated blood to the tibial and peroneal arteries and their smaller branches, the velocity and flow increases. The viscosity of the blood decreases and the red blood cells reach a desirable state of deformability. These erythrocytes are able, with increased velocity and ellipsoidal shape, to reach tissue they were blocking or unable to migrate through previously. In addition to the enhanced perfusion of compromised tissues, the increase in blood flow and passive exercise in often debilitated muscles, reduces the effects of muscle disuse atrophy. This sets in motion a therapeutic cycle of increased mobility by the patient. When walking and weight bearing is desirable, the patient is literally contributing to their own improvement in circulatory status by increased walking and well-being.
.
Prior to the procedure and machine herein described, there are well-defined protocols for treatment of wounds. Many of these same protocols are followed in conjunction with the present methods. A similar example obtains with chemotherapy in the treatment of malignant tumors. In chemotherapy, besides attacking the target tumor, there are numerous undesirable side effects. The side effects would be less if the chemotherapy dosage were reduced. The effect on the tumor would also be reduced, unless there were some means to make the tumor more susceptible to the chemotherapy. It is found that the present methods have precisely that effect by increasing fluid perfusion in the tumor and the vicinity thereof.
.
(Technical readouts omitted)

... Thus, it is apparent that there has been provided, in accordance with the invention, a procedure and machine that fully satisfy the objects, aims and advantages set forth above. While the invention has been described in conjunction with a specific embodiment thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art and in light of the foregoing description. Accordingly, it is intended to embrace all such alternatives, modifications and variations as fall within the spirit of the appended claims.

MicroVas Systems International, LLC

2011-04-01T10:50:00.000-07:00

MicroVas Patent # 6,745,078 (excepts)

2011-04-01T09:34:00.000-07:00

PROCEDURE AND MACHINE FOR ELECTRO-INDUCING/STIMULATING DEEP-LAYERED MUSCLE CONTRACTIONS USING A BIPHASIC FARADIC PULSE SEQUENCE

Document Type and Number:

WIPO Patent Application WO/2003/090845

Kind Code: A2

Abstract:

A procedure and machine promotes healing by causing muscle fasciculation and contraction relaxation cycles that effectively pump blood through the microcirculation, draining the venous beds and raising the tissue oxygen levels. A high phase charged system, a power source (34), timer (31) and pulse generator (32) is electronically pulsed and adjusting to induce deep-layered muscle contractions, causing greatly increased flow rates of both blood and lymphatics, patency of vessels permitting, and forcing blood into the microcirculation of the treated tissue. The machine electrical waveform stimulates angiogenesis, facilating new tissue growth and repair in the healing process and raises the metabolic rate in the treated tissues.

Inventors: Buchner, Kelly Wayne (3171-A S. 129th E. Ave, Tulsa, OK, 74134, US)

Application Number: PCT/US2003/012685

Publication Date: November 06, 2003

Filing Date: April 24, 2003

Assignee: MICROVAS TECHNOLOGIES, INC. (6130 S. Memorial, Tulsa, OK, 74133, US)

International Classes: A61N1/00; A61N1/04; A61N1/18; A61N1/36

Attorney, Agent or Firm: Catalano, Frank J. (Gable & Gotwals, 1100 Oneok Plaza 100 West 5th Stree, Tulsa OK, 74103-4217, US)

Claims:

AMENDED CLAIMS [received by the International Bureau on 22 January 2004 (22.0

1.	04); original claim 1 canceled, original claims 25 replaced by new claims 25, claims 611 added (2 pages)] (Claim 1 canceled).

A procedure for therapeutic treatment of human and animal tissues comprising the steps of : identifying the tissue to be treated; sandwiching the identified tissue between one or more pairs of opposed emitter pads in contact with the skin; and applying a pulse sequence to the pairs of emitter pads to stimulate deep layered muscle contractions in the identified tissues, said pulse sequence being a biphasic rectangular pulse sequence having a waveform with nominal parameters including a duty cycle of approximately a 1. 5 seconds on and 1.5 seconds off.

3.	A procedure according to claim 2, said nominal parameters further including a repetition frequency of approximately 57 Hz.

4.	A procedure according to claim 2, said nominal parameters further including a pulse width of approximately 110 microseconds.

5.	A procedure according to claim 2 further comprising the steps of : setting the intensity of the pulse sequence at an initial level; and incrementally increasing the intensity in response to the tolerance level of the patient.

6.	A procedure according to claim 2, said nominal parameters further including a pulse period of approximately 18 miliseconds.

7.	A procedure according to claim 6, said nominal parameters further including a time between initiation of positive and negative pulses of approximately 9 miliseconds.

8.	A procedure according to claim 2, said nominal parameters including a peak open circuit voltage of approximately 140 volts with an output impedance of approximately 500 ohms.

10.	A procedure according to claim 9, said nominal parameters further including a time between initiation of positive and negative pulses of 9 miliseconds.

11.

A procedure according to claim 10, said nominal parameters including a peak open circuit voltage of approximately 140 volts with an output impedance of approximately 500 ohms. STATEMENT UNDER ARTICLE 19 (1) This statement specifically refers to the Amendment of Claims Under Article 19 filed on even date herewith for International Application Number PCT/US03/12685 entitled PROCEDURE AND MACHINE FOR ELECTROINDUCING/STIMULATING DEEP LAYERED MUSCLE CONTRACTIONS USING A BIPHASIC FARADIC PULSE SEQUENCE. Applicant submits this Amendment of Claims to further define patentable aspects of the invention. The claim amendments are within the scope of the invention disclosure, and the amendments are expected to have no impact on the description or drawings. This Amendment also conforms the claims to the claims as allowed in the priority application.
.

Description:
.

PROCEDURE AND MACHINE FOR ELECTRO-INDUCING/STIMULATING DEEP-LAYERED MUSCLE CONTRACTIONS USING A BIPHASIC FARADIC PULSE SEQUENCE BACKGROUND OF THE INVENTION : This invention generally relates to therapeutic treatment of human and animal tissues and more particularly concerns a procedure and machine for electro-inducing or stimulating deep layered muscle contractions in tissues for the purpose of healing and treating wounds and various vascular deficiency ailments such as peripheral vascular disease, ischemic rest pain, diabetic neuropathy, pressure ulcers, slow or non-healing wounds, chronic low back pain, osteoarthritis, occupational problems such as carpal-tunnel syndrome, tendonitis and other sports injuries.
.
An underlying characteristic of the above conditions and diseases is impaired circulation in-the capillary beds as well as nerve damage. Without blood flow to the tissues, oxygen and nutrients cannot get into the tissues and the waste products of metabolism cannot get out. This puts a severe stress on the tissues causing them to go into a survival mode. The cells use what limited resources they have to stay alive and higher functions, including healing and repair, as well as tissue mediated immunity, become essentially shut down. In most patients with severe disease, measured tissue oxygen levels have been found to be less than 15% of normal. Diabetics with impaired basement membrane function, Reynauds phenomena, Claudication states and other similar conditions all may have similar features due to this underlying characteristic.
.
Essentially, every tissue in the body has intrinsic electrical properties.
.
Because of this, it has been found that they respond to electrical stimulation.
.
There have been many machines designed over the years to use electricity to affect the body in various ways to enhance the healing process. There are many variables in the use of electricity, including polarity, voltage, amperage,frequency and waveform. Although there are a variety of alternate technologies available today, the electronic parameters of known machines have limited applications.
.
Hyperbaric oxygen therapy has been shown to be effective in healing ischemic ulcers. 100% oxygen at 2 atmospheres will give a partial pressure of oxygen 10 times normal. This greatly increases the rate of diffusion through the open face of the ulcer. Skin, however, is not as permeable to oxygen diffusion and oxygen delivery depends upon intact circulation as well. Hyperbaric oxygen therapy is a passive process and does not alter the underlying disease in the microcirculation.
.
There are several procedures in practice using moist heat with occlusion dressings, infrared lamps, membranes with electrical currents and warm water whirlpool treatments. These have all shown some merit and have been effective in varying degrees. They all work by stimulating the arterioles in the capillary beds to dilate in response to infrared energy. These also are passive procedures, however, and do not alter the underlying disease in the microcirculation.
.
Machines using high frequency interferential electrical currents are also effective. They stimulate the nerves in the skin and cause dilation of the capillary beds through the reflex pathways. However, this form of electrical current tends to be more superficial in the tissues and, therefore, less decisive and rapid in its healing effects.
.
Another procedure being used today consists of a garment placed around the diseased limb. Intermittent compression is then administered via compressed air from the attached machine. This again has proven to be effective to promote circulation and healing. by pumping the blood through the capillary beds. Pressure gradients are increased in the capillary beds but there is not necessarily the dilation of the arterioles as the other methods promote.
.
This procedure does not remodel the microcirculation either.
.
It is, therefore, an object of this invention to provide an electrical tissue treating procedure and machine which increases circulation in capillary beds.
.
Another object of this invention is to provide an electrical tissue treating procedure and machine which significantly remodels microcirculation so as to provide more permanent therapeutic improvement. A further object of this invention is to provide an electrical tissue treating procedure and machine which not only dilates arterioles but also, increases pressure gradients across the capillary beds to improve flow and oxygen levels and promote angiogenesis.
.
Yet another object of this invention is to provide an electrical tissue treating procedure and machine which provides deep layered muscle contractions and perfuses tissues with blood so as to afford more decisive and rapid healing than known methods and machines. It is also an object of this invention to provide an electrical tissue treating procedure and machine which facilitates more rapid and decisive healing of vascular deficiency ailments than known procedures and machines.
.
SUMMARY OF THE INVENTION : In accordance with the invention, a procedure and machine are provided to promote healing by causing muscle fasciculation and contraction relaxation cycles that effectively pump blood through the microcirculation, draining the venous beds and raising the tissue oxygen levels. This, in turn, supplies the oxygen and substrates necessary to greatly accelerate the healing process.
.
Pressure gradients are actually increased across the capillary beds with perfusion of blood into the designated area of the patient, in contrast to merely dilating the capillary beds. Therefore, the treatment has a potent effect on the microcirculation, which results in dramatic responses to treatment.
.
Transcutaneous oxygen monitors have demonstrated marked increases in tissue oxygen levels within minutes of initiating treatment. Tissue oxygen levels with successive treatments continue to improve.
.
A high phase charged system is electronically pulsed and adjusted to induce deep-layered muscle contractions, causing greatly increased flow rates of both blood and lymphatics, patency of vessels permitting, and forcing blood into the microcirculation of the treated tissue.
.
The machine electrical waveform stimulates angiogenesis, that is, budding of new capillaries and generation of denser capillary networks in the tissues. This lays the groundwork for new tissue growth and repair in the healing process. The machine electrical waveform also raises the metabolic rate in the treated tissues, which, it is theorized, helps the intimal lining of the arteries to metabolize the excess unused nutrients clogging them. Whatever the actual cause, the effect is improved blood flow that has been shown to be permanent, particularly in patients with neuropathy.
.
The procedure and machine have been tested on diabetics with severe ischemic ulcers in feet that were destined for amputation. This condition is usually associated with underlying osteomeyelitis, which does not respond well to standard therapy including systemic antibiotics and wound care. The present treatment greatly improves the management of this condition because theenhanced blood flow brings enhanced levels of antibiotics and healing to the affected area. In almost every case, the feet have been salvaged.
.
In addition, the machine's electrical waveform directly stimulates the activity of fibroblasts in the healing process. In the healing of ischemic ulcers the fibroblasts act first to build the framework upon which further cell types including skin and capillaries grow. The electrical current is a deep penetrating current that affects all tissues from the skin to the bone. Technically, the machine generates an [electrical] field between the emitter pads, in contrast to the electrical waveform of some machines that stay rather superficial in the tissues affecting primarily the top several millimeters. The system stimulates activity in bone cells as well, which accelerates fracture healing.
.
Finally, the procedure and machine have achieved excellent test case success in reversing neuropathy in the feet and legs of diabetics being treated.
.
In follow up on this condition thus far, improvement has persisted for extended periods of time. There is no other known technology or treatment modality that has reversed diabetic neuropathy. The reason for this unique therapeutic benefit is not known. It may be due to improvement in the circulation that nourishs the nerves or due to an unknown direct action on the nerves themselves.
.
The procedure and machine have shown remarkable efficacy in dealing with the above difficult disease states. In comparison with the current alternative technologies on the market today, the present treatment has proven to cause more rapid and decisive healing. In addition, the patients have enjoyed permanent, persistent improvements in the circulation of the affected limb.
.
A treatment regimen of forty-five minutes a day has been effective in a very high percentage of patients treated resulting in remarkable changes in both neural conductivity and wound healing rates. Most importantly, patients report a high level of comfort with treatment.
.
Even with a relatively high phase charge, the comfort level to the patient remains acceptable over extended periods of time, during which the muscle groups are contracting. During moderate muscle contraction, blood rates can increase from 10 to 25 times the patient's resting blood flow. While only 20 to 25 percent of muscle capillaries are open during rest, nearly all of the dormant capillaries open up during moderate muscle contraction. Because of the decreased oxygen concentration in the tissue fluid (because of increased oxygen demands from the contracting muscles), vasodilation of the vessels is triggered by release of adenosine and other vasodilator substances, to the extent that any vasodilation is possible. In addition, lymph will not flow freely from resting muscle. However, the contracting muscles will squeeze or pump the lymph vessels and capillaries resulting in increased flow rates. With this increased fluid perfusion due to passive repetitive contractions (static work, an unopposed, involuntary muscle contraction) there is little tactic acid build up and most importantly there is more oxygenated blood, due to the pumping action of the muscles exerted on the arterial side.

As an example, take the lower leg as an area to be treated for healing a diabetic ulcer on the foot. The emitter pads are applied to the anterior and posterior muscle compartments of the lower leg. This will achieve muscle contractions in the anterior compartment, consisting of the anterior tibial and the extensor group and of the posterior compartment consisting of the gastrosoleus, flexors and peroneals. As these muscles pump oxygenated blood to the tibial and peroneal arteries and their smaller branches, the velocity and flow increases. The viscosity of the blood decreases and the red blood cells reach a desirable state of deformability. These erythrocytes are able, with increased velocity and ellipsoidal shape, to reach tissue they were blocking or unable to migrate through previously. In addition to the enhanced perfusion of compromised tissues, the increase in blood flow and passive exercise in often debilitated muscles, reduces the effects of muscle disuse atrophy. This sets in motion a therapeutic cycle of increased mobility by the patient. When walking and weight bearing is desirable, the patient is literally contributing to their own improvement in circulatory status by increased walking and well-being.
.
Prior to the procedure and machine herein described, there are well- defined protocols for treatment of wounds. Many of these same protocols are followed in conjunction with the present methods. A similar example obtains with chemotherapy in the treatment of malignant tumors. In chemotherapy, besides attacking the target tumor, there are numerous undesirable side effects. The side effects would be less if the chemotherapy dosage were reduced. The effect on the tumor would also be reduced, unless there were some means to make the tumor more susceptible to the chemotherapy. It is found that the present methods have precisely that effect by increasing fluid perfusion in the tumor and the vicinity thereof.
.
(technical data omitted)

... Thus, it is apparent that there has been provided, in accordance with the invention, a procedure and machine that fully satisfy the objects, aims and advantages set forth above. While the invention has been described in conjunction with a specific embodiment thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art and in light of the foregoing description. Accordingly, it is intended to embrace all such alternatives, modifications and variations as fall within the spirit of the appended claims

neuroVasix v. Microvas Technologies, Inc

2011-03-01T07:53:00.000-08:00

neuroVasix, inc. v. MicroVas Technologies, Inc. CJ-2006-7955 Issues Case Summary
All judgments in favor of MTI and its founder, and against neuroVasix (9 issues). OSCN listing.
.
neuroVasix, inc. v. MicroVas Technologies, Inc. CJ-2006-7955 Entire Case Summary
(Oklahoma State Courts Network online) (offsite)
.
neuroVasix Liable for Fraud, Breach of Contract (Transcript, March 10, 2009)
results of jury trial, Tulsa County, transcript of Journal Entry of Judgment, more than $1million in judgments against neuroVasix
.
Journal Entry of Judgment (Scans)
March 10, 2009

An Official Complaint and Preliminary Investigation on the Misconduct of NeuroVasix, inc.
for FDA Case number 68749 (excerpts), filed on November 21, 2008
.

.........................

6130 South Memorial Drive, Tulsa, OK 74133

Phone: 918-250-9996 or Toll Free: 1-86-MICROVAS

Fax: 918-252-4888 email: info@microvas.com

NeuroVasix Liable for Fraud, Breach of Contract

2009-02-18T11:58:00.000-08:00

IN THE DISTRICT COURT IN AND FOR TULSA COUNTY

STATE OF OKLAHOMA

..........................NEUROVASIX, INC., ................. ..........)

.......................................................................................)

...................................... Plaintiff, ..................................)

..........................v. ..........................................................)

........................................................................................) ........ Case No. CJ-2006-7955

..........................MICROVAS TECHNOLOGIES, INC. ........)

........................... AND KELLY WAYNE BUCHNER..............)

........................... a/k/a/ K. WAYNE BUCHNER ................)

........................... ............................................................)

..................................... Defendants. ..............................) ........ Consolidated

..........................-----------------------------------------------------------..) .................... with

........................... ............................................................)

..........................NEUROVASIX, INC., ..............................)

........................... ............................................................)

....................................... Plaintiff, ..................................) ........ Case No. CJ-2006-6717

..........................v. ..........................................................)

........................... ............................................................)

..........................MICROVAS TECHNOLOGIES, INC. .........) ....... Judge Michael Gassett

..........................AND JEROME STEELE ...........................)

........................... ............................................................)

.................................... Defendants. ...............................)
.

JOURNAL ENTRY OF JUDGMENT ON JURY VERDICT
.

On February 2, 2009, the above-captioned case came on for trial. The Plaintiff, Neurovasix, Inc (“Neurovasix”), appeared by and through its corporate representative and counsel of record, John E. Howland. The Defendant, Kelly Wayne Buchner (“Buchner”), appeared in person and the Defendant, Microvas Technologies Inc. (“Microvas”), appeared by and through its corporate representative and counsel of record, Steven J. Adams and Robert L. Smith.
.

This case includes claims and defenses to be tried by the Court, without a jury, as well as claims and defenses to be tried to a jury. On February 2, 2009, the parties announced they were ready to proceed with the trial. A jury trial as to those claims and defenses to be presented to the jury was conducted and completed. Before Trial, Neurovasix filed a written request for proposed findings of fact and conclusions of law for the claims to be decided by the court. Because (1) all claims have not been decided and (2) the Court has not set off against the jury verdicts those recoveries awarded to Neurovasix against Microvas and Buchner in its prior orders on Neurovasix’s motion for summary judgment, this Judgment is not a final judgment as recognized by OKLA. STAT. tit. 12, § 994 and, accordingly, execution may not issue. A final judgment will be entered in connection with the court’s decision on the claims and defenses to be decided by the Court, and after considering pre-judgment and post-judgment interest on the jury verdict judgments, costs, attorney fees if applicable, and any offset rights of Neurovasix.
.

After hearing all evidence on those claims to be considered by the jury and after receiving the Court’s instructions of applicable law, the jury returned its verdicts in favor of Microvas and Buchner and against Neurovasix. The Court finds that each Jury Verdict Form on each cause of action submitted to the jury was in all respects proper and is accepted by the Court.
.

IT IS THEREFORE ORDERED, ADJUDGED AND DECREED by the Court, based upon the jury verdict, signed by ten (10) of the twelve (12) jurors, on Buchner’s claim for fraud, that judgment is rendered in favor of Kelly Wayne Buchner and against Neurovasix, Inc, in the amount of Seven Hundred Fifty-Five Thousand and no/100ths Dollars ($755,000.00).
.

IT IS THEREFORE ORDERED, ADJUDGED AND DECREED by the Court, based upon the jury verdict, signed by ten (10) of the twelve (12) jurors, on Microvas Technologies, Inc.’s claim for fraud, that judgment is rendered in favor of Microvas Technologies, Inc and against Neurovasix, Inc. in the amount of Three Hundred Forty-One Thousand and no/100ths ($341,000.00).
.

IT IS THEREFORE ORDERED, ADJUDGED AND DECREED by the Court, based upon the jury verdict, signed by eleven (11) of the twelve (12) jurors, on Buchner’s claim for breach of the Consulting Services Agreement, that judgment is rendered in favor of Kelly Wayne Buchner and against Neurovasix, Inc. in the amount of Fifty-Six Thousand and no/100ths ($56,000.00).
.

IT IS THEREFORE ORDERED, ADJUDGED AND DECREED by the Court, based upon the jury verdict, signed by eleven (11) of the twelve (12) jurors, on Neurovasix’s claim for breach of the license agreement contained in March 22, 2005 “Security Agreement,” that judgment is rendered in favor of Microvas Technologies, Inc. and against Neurovasix, Inc.
.

Signed this 9 day of Match, 2009.

J. MICHAEL GASSETT (Stamped)......

Hon. Michael Gassett .......................

Judge of the District Court..................

APPROVED AS TO FORM:

John E. Howland (signed) ..................... Steven J. Adams (signed)

John E. Howland, OBA No. 4416 ............Steven J. Adams, OBA No. 142

Micah T. Zomer, OBA No. 22347 ............Charles R. Willing, OBA No. 15873

ROSENSTEIN, FIST & RINGOLD .......... Fellers, Snider, Blankenship, Bailey

525 South Main, Suite 700 .................... & Tippens, P.C.

Tulsa, OK 74103 .................................. The Kennedy Building

........................................................... 321 South Boston Avenue, Ste 800

ATTORNEYS FOR PLAINTIFF .............. Tulsa, Oklahoma 74107-3318

NEUROVASIX, INC. ............................. (918) 925-5835

........................................................... Fax (918) 583-9659

.......................................................................... and

............................................................Robert L. Smith, OBA No. 11706

............................................................Law Office of Robert L. Smith

............................................................717 South Houston, Suite 400

............................................................Tulsa, Oklahoma 74127-9007

............................................................ATTORNEYS FOR DEFENDANTS

............................................................MICROVAS TECHNOLOGIES, INC.

............................................................AND WAYNE BUCHNER

To view scanned images of this document, click here.

Update: Microvas Technologies Inc vs. Neurovasix Inc

2009-02-17T11:43:00.000-08:00

Excerpt from the Journal Entry of Judgment on Jury Verdict, filed March 10, 2009.

. . . ". . . After hearing all evidence on those claims to be considered by the jury and after receiving the Court's instructions of applicable law, the jury returned its verdicts in favor of Microvas and Buchner and against Neurovasix. The Court finds that each Jury Verdict Form on each cause of action submitted to the jury was in all respects proper and is accepted by the court."

The Full Document appears below (click on each sheet to enlarge)

To Read a transcript of this document, click here.

Patent Assignment from Buchner to MTI (Scans)

2008-04-05T20:29:00.000-07:00

To read a transcript of this document, click here.

MicroVas Patent Awarded

2008-02-25T12:22:00.000-08:00

MicroVas Awarded Patent #US 6,745,078 B1

. The U. S. Patent Office issued patent number 6,745,078 on June 1, 2004 for the invention titled, "Procedure and machine for electro-inducing/stimulating deep layered muscle contractions using a biphasic faradic pulse sequence".
.
. MicroVas Technologies, Inc. is the exclusive licensee for the invention. The patent covers the essential technology that enables the MicroVas Electrical Stimulation System to achieve the results that it does for the treatment of 84 different conditions. These include diabetic neuropathies, chronic wounds, and carpal tunnel syndrome. Foreign patents are currently pending in over 100 countries.

Jerome Steele Appointed CEO of MTI (Scan)

2008-02-24T20:37:00.000-08:00

To read a transcript of this document, please click here.

Jerome Steele Appointed CEO of MTI

2008-02-24T12:29:00.000-08:00

CERTIFICATE OF ACTION

BOARD OF DIRECTORS OF

MICROVAS TECHNOLOGIES, INC.

March 21, 2005

The undersigned, being the sole Director of MicroVas technologies, Inc., incorporated under the laws of the State of Oklahoma, hereby adopts the following Resolutions, and declares that the same shall be and constitute actions of the Board of Directors:

"RESOLVED, that the following named persons be and they are hereby elected to fill the position set out opposite their names:

Name ...................... Office
K. Wayne Buchner .. Chairman of the Board
Jerome Steele .......... Chief Executive Officer
Janie Buchner .......... Vice President and Secretary

This Certificate of Action by the Board of directors is executed pursuant to Section 1027(F)(1) of the General Corporation Act of the State of Oklahoma, providing that action which might be taken at a meeting of the Board of Directors may be taken without a meeting if a record thereof be made in writing and signed by all the members of the Board.
.

Dated the day and year first above stated.

(signed)

K. Wayne Buchner
.

To View a Scan of the Original Document, please Click here.

Patent Assignment from Buchner to MTI

2008-02-23T13:03:00.000-08:00

PATENT ASSIGNMENT

.......... IN CONSIDERATION OF good and valuable consideration, receipt of which is hereby acknowledged, I, Kelly W. Buchner, a citizen of the United States of America, residing at (old addressed crossed out by hand and replaced by new address, initialed WB) (hereinafter referred to as "Assignor") do hereby sell, transfer, set over and assign unto Microvas Technologies, Inc, an Oklahoma corporation, having a principle place of business at (old address crossed out by hand and replaced by 6130 So. Memorial Drive, Tulsa, OK 74133, initialed WB), (hereinafter referred to as "Assigneee"). its successors, assigns, nominees, or other legal representatives all of my entire right, title and interest, in all countries throughout the world, including the rigts to claim convention priority, in and to the invention entitled:

Procedure and Machine for Electro-Inducing/Stimulating Deep Layered Muscle Contractions Using a Biphasic Faradic Pulse Sequence

and all improvements thereto, and all patents and patents applications issued or filed thereon, including but not limited to:

AU2003228673 A1 - 2003-11-10

BR0309666 A - 2005-03-01

CA2483412 A1 - 2003-11-06

EP1501587 A2 - 2005-02-02

US6745078 B1 - 2004-06-01

US2005033387 A1 - 2005-02-10

WO03090845 A2 - 2003-11-06

WO03090845 A3 - 2004-05-13

WO03090845 B1 - 2004-06-24

and all other United States and foreign patnets and patent applications in said invention, whether or not claiming convention priority thereon, and any continuation, division, renewal, or substitute thereof, and as to letters patent any reissue or re-examinatin thereof, and reques to all officials of any country whose duty is to issue letters patent to issue said letters patent in the name of Assignee;

...... Assignor hereby covenants that no assignment, sale, agreement or encumbrance has been or will be made or entered into which would conflict with this Assignment; and

...... Assignor further covenants that:

...... I will promptly provide Assignee, at its request, with all pertinent facts and documents relating to said invention, said patents and said applications and all other patent applications to be filed thereon, and any letters patent issuing thereon, as may be known or accessible, and will testify to the same in any interference, litigation or proceeding related thereto, and

...... I will promptly execute and deliver to assignee or its legal representative any and all papers, instruments or affidavits required to apply for, obtain, maintain, issue and enforce said invention, said patents and said applications and any other patent application filed on said invention, whether or not claiming convention priority thereon, and any letters patent issuing thereon, and any continuation, continuation-in-part, division, renewal, or substitute thereof, and as to letters patent any reissue or re-examination thereof, which may be necessary or desireable to carry out the purpose thereof:

(signed)

Kelly W. Buchner

Date: 6-8-05

Citizenship: USA

Residence and post office addresses: (old address crossed out by hand, replaced with new, intialled WB)

STATE OF OKLAHOMA

COUNTY OF .... Tulsa
.

...... On this 8th day of June, 2005, before me personally came the above named Kelly W. Buchner, to me personally known, or who produced .... OKLA DL .... as identification, as the individual who executed the foregoing Assignmemt, and acknowledged to me that he executed the same of his own free will for the purposes set forth theren.

(Signed and notarized) Terri C. Lauderdale

Notay Public, State of .... OKLA .... at Large

My Commission Expires: 12-08-08

Notary # 04011031

To view scanned images of the original document, click here

Jerome Steele Appointed Chairman of the Board of MTI (Scan)

2008-02-21T20:48:00.000-08:00

To view a transcript of this document, please click here.

Jerome Steele Appointed Chairman of the Board of MTI

2008-02-21T13:45:00.000-08:00

CERTIFICATE OF ACTION OF

BOARD OF DIRECTORS OF

MICROVAS TECHNOLOGIES, INC

December 2, 2005

The undersigned, being the sole Director of MicroVas Technologies, Inc., Incorporated under the laws of the Sate of Oklahoma, hereby adopts the following Resolutions, and declares that the same shall be and constitute actions of the Board of Directors:

Resolved, that the following named persons be and they are hereby elected to fill the positions set out opposite their names:
.
Name ............................ Office
.
Jerome Steele ................ Chairman of the Board, Chief Executive Officer
.
Daniela Salazar .............. Secretary
.
This Certificate of Action by the Board of Directors is expressed pursuant to Section 1027(F)(1) of the General Corporation Act of the State of Oklahoma, providing that action which might be taken at a meeting of the Board of Directors may be taken without a meeting if a record thereof be made in writing and signed by all the members of the Board.
.
Dated the day and year first above stated.
.
(signed)
.
K. Wayne Buchner
.

To view the original scanned document, click here.

Resignation of Kelly Wayne Buchner, Release of Liabilities (Scan)

2008-02-20T20:56:00.000-08:00

To view a transcript of this document, please click here.

Resignation of K. Wayne Buchner, Release of Liabilities

2008-02-20T14:02:00.000-08:00

RESIGNATION

.
Effective December 2, 2005, I resign as an officer and director of MicroVas Technologies, Inc. (MTI). I release MTI, its officers, directors, shareholders, agents, representatives, and employees and neurovasix, inc., its officers, directors, shareholders, agents, representatives and employees from all liabilities. I acknowledge receipt of $20.00 in consideration of the foregoing.
.
(signed)
K. Wayne Buchner
.

To view a scan of the original document, please click here

FDA Establishment Registration

2008-02-19T12:59:00.000-08:00

Click on the above image to enlarge